GUAITOLI, GIAMBATTISTA
 Distribuzione geografica
Continente #
NA - Nord America 1.373
EU - Europa 833
AS - Asia 174
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 2.385
Nazione #
US - Stati Uniti d'America 1.367
GB - Regno Unito 317
IT - Italia 101
DE - Germania 100
CN - Cina 88
FR - Francia 78
SE - Svezia 69
PL - Polonia 61
UA - Ucraina 35
TR - Turchia 29
FI - Finlandia 25
HK - Hong Kong 20
SG - Singapore 20
BG - Bulgaria 16
RU - Federazione Russa 10
BE - Belgio 8
CA - Canada 6
IN - India 6
IE - Irlanda 4
IR - Iran 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
EU - Europa 2
ID - Indonesia 2
MD - Moldavia 2
MY - Malesia 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
ES - Italia 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PK - Pakistan 1
TZ - Tanzania 1
Totale 2.385
Città #
Southend 279
Fairfield 173
Chandler 136
Ashburn 124
Woodbridge 124
Ann Arbor 107
Houston 82
Cambridge 70
Jacksonville 67
Dearborn 63
Kraków 60
Frankfurt am Main 57
Seattle 55
Nyköping 54
Wilmington 41
Modena 24
Beijing 21
New York 21
Hong Kong 19
Izmir 18
Princeton 18
Fremont 17
Des Moines 16
Sofia 16
San Diego 14
Eugene 13
Shanghai 12
Helsinki 11
Milan 10
Redwood City 9
Brussels 7
Singapore 6
Bremen 5
Grafing 5
Dublin 4
London 4
Los Angeles 4
Nanjing 4
San Mateo 4
Boardman 3
Guangzhou 3
Hefei 3
Norwalk 3
Siena 3
Toronto 3
Acate 2
Arceto 2
Brno 2
Casagiove 2
Chisinau 2
Collecchio 2
Dong Ket 2
Dongguan 2
Indiana 2
Jakarta 2
Kish 2
Kunming 2
Ottawa 2
Paris 2
Parma 2
Saint Petersburg 2
Albinea 1
Amsterdam 1
Andover 1
Atlanta 1
Baotou 1
Changsha 1
Chapel Hill 1
Chengdu 1
Dar es Salaam 1
Dübendorf 1
Edinburgh 1
Faisalabad 1
Fuzhou 1
Gainesville 1
Heze 1
Kilburn 1
Leawood 1
Leipzig 1
Louvain 1
Misterbianco 1
Mountain View 1
Nanchang 1
Nave 1
New Orleans 1
Ningbo 1
Pavia 1
Phoenix 1
Prato 1
Pune 1
Rome 1
Serra 1
Shenyang 1
Southampton 1
Taiyuan 1
Tokyo 1
Turku 1
Vancouver 1
Verona 1
Warsaw 1
Totale 1.863
Nome #
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 278
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. 228
Alanine Mutants of the Interface Residues of Human Thymidylate Synthase Decode Key Features of the Binding Mode of Allosteric Anticancer Peptides 210
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescenceresonance energy transfer. 193
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding. 193
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 183
Allosteric Inhibition of human Thymidylate Synthase. 177
Ligand-Based Virtual Screening and ADME-Tox Guided Approach to Identify Triazolo-quinoxalines as Folate Cycle Inhibitors. 175
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 151
Pirrole-amidine oligopeptide–DNA interaction studies through Isothermal Titration Calorimetry 150
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 145
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 124
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 113
Erratum: Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 34 (E542-E549) DOI: 10.1073/pnas.1104829108) 98
Totale 2.418
Categoria #
all - tutte 7.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020442 37 14 12 26 60 64 70 51 42 14 25 27
2020/2021461 43 22 56 32 55 20 45 58 23 77 18 12
2021/2022279 11 36 3 4 9 24 10 10 29 22 83 38
2022/2023350 27 47 22 42 32 60 2 42 39 2 19 16
2023/2024261 9 9 19 18 95 40 8 15 4 7 16 21
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 2.418